Characterization of morphological alterations in micropapillary adenocarcinoma of the lung using an established cell line. 2022

Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa 252‑0374, Japan.

Micropapillary adenocarcinoma of the lung is a type of cancer associated with a poor prognosis and is characterized by the presence of tumor cells with a ring‑like glandular structure floating within alveolar spaces. In the present study, the association between its morphological, biochemical and immunohistochemical characteristics, and malignancy was investigated using the KU‑Lu‑MPPt3 cell line established from a patient with MIP adenocarcinoma. Two subpopulations of KU‑Lu‑MPPt3 cells, namely adhesive (AD) and clumpy and suspended (CS) cells, were prepared and subjected to DNA microarray, reverse transcription‑quantitative PCR, western blot and immunostaining analyses. Protein expression patterns were compared between the cell types and their derived tissues using immunostaining. The results revealed similar protein expression patterns between the tumor cells found in the alveolar spaces and CS cells, which exhibited morphological characteristic of MIP adenocarcinoma. Based on the results of DNA microarray analysis, the present study then focused on Akt and focal adhesion kinase (FAK), which were markedly activated in the KU‑Lu‑MPPt3 CS and AD cells, respectively. Following KU‑Lu‑MPPt3 CS cell plating onto collagen‑coated culture dishes, some cells exhibited a transformation of their morphology into KU‑Lu‑MPPt3 AD‑like cells within a few days, and their Akt and FAK activities were similar to those of the AD cells. Additionally, the inhibition of Akt and FAK activities with Akt and FAK inhibitors reduced KU‑Lu‑MPPt3 CS cell adhesion and proliferation. Thus, the aforementioned results indicated that the phosphorylation of FAK and Akt may play a crucial role in the regulation of KU‑Lu‑MPPt3 CS cell adhesion and proliferation, respectively. Furthermore, the malignant potential of MIP adenocarcinoma may be attributed to these morphological and biochemical alterations in the KU‑Lu‑MPPt3 cells.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051057 Proto-Oncogene Proteins c-akt Protein-serine-threonine kinases that contain PLECKSTRIN HOMOLOGY DOMAINS and are activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. They play a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells. akt Proto-Oncogene Protein,c-akt Protein,AKT1 Protein Kinase,AKT2 Protein Kinase,AKT3 Protein Kinase,Akt-alpha Protein,Akt-beta Protein,Akt-gamma Protein,Protein Kinase B,Protein Kinase B alpha,Protein Kinase B beta,Protein Kinase B gamma,Protein-Serine-Threonine Kinase (Rac),Proto-Oncogene Protein Akt,Proto-Oncogene Protein RAC,Proto-Oncogene Proteins c-akt1,Proto-Oncogene Proteins c-akt2,Proto-Oncogene Proteins c-akt3,RAC-PK Protein,Rac Protein Kinase,Rac-PK alpha Protein,Rac-PK beta Protein,Related to A and C-Protein,c-akt Proto-Oncogene Protein,Akt alpha Protein,Akt beta Protein,Akt gamma Protein,Akt, Proto-Oncogene Protein,Protein, akt Proto-Oncogene,Protein, c-akt Proto-Oncogene,Proteins c-akt1, Proto-Oncogene,Proteins c-akt2, Proto-Oncogene,Proteins c-akt3, Proto-Oncogene,Proto Oncogene Protein Akt,Proto Oncogene Protein RAC,Proto Oncogene Proteins c akt,Proto Oncogene Proteins c akt1,Proto Oncogene Proteins c akt2,Proto Oncogene Proteins c akt3,Proto-Oncogene Protein, akt,Proto-Oncogene Protein, c-akt,RAC PK Protein,RAC, Proto-Oncogene Protein,Rac PK alpha Protein,Rac PK beta Protein,Related to A and C Protein,akt Proto Oncogene Protein,alpha Protein, Rac-PK,c akt Proto Oncogene Protein,c-akt, Proto-Oncogene Proteins,c-akt1, Proto-Oncogene Proteins,c-akt2, Proto-Oncogene Proteins,c-akt3, Proto-Oncogene Proteins
D051416 Focal Adhesion Protein-Tyrosine Kinases A family of non-receptor, PROLINE-rich protein-tyrosine kinases. Focal Adhesion Protein-Tyrosine Kinase Family,Focal Adhesion Kinase,Focal Adhesion Protein-Tyrosine Kinase,Focal Adhesion Protein Tyrosine Kinase Family,Focal Adhesion Protein Tyrosine Kinases

Related Publications

Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
January 2018, Journal of cancer research and clinical oncology,
Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
February 2016, Molecular and clinical oncology,
Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
August 1988, Cancer genetics and cytogenetics,
Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
August 2019, Annals of diagnostic pathology,
Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
October 2017, Journal of thoracic disease,
Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
January 1998, Anticancer research,
Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
December 1989, Acta pathologica japonica,
Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
October 1984, The Indian journal of medical research,
Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
November 1979, Cancer research,
Dai Sonoda, and Koki Kamizaki, and Yukiko Matsuo, and Kana Aruga, and Masashi Mikubo, and Keishi Yamashita, and Michiru Nishita, and Yasuhiro Minami, and Yukitoshi Satoh
May 2012, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Copied contents to your clipboard!